The blood lipid regulation of Monascus -produced monascin and ankaflavin via the suppression of low-density lipoprotein cholesterol assembly and stimulation of apolipoprotein A1 expression in the liver

Abstract Background/Purposes Monascin (MS) and ankaflavin (AK) produced by Monascus purpureus NTU 568 were proven to show excellent hypolipidemic effects in our previous studies; however, the mechanism is still unclear. Methods This study used MS, AK, and monacolin K as test substances and performed...

Full description

Saved in:
Bibliographic Details
Published inJournal of microbiology, immunology and infection Vol. 51; no. 1; pp. 27 - 37
Main Authors Lee, Chun-Lin, Wen, Ja-Yan, Hsu, Ya-Wen, Pan, Tzu-Ming
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 01.02.2018
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background/Purposes Monascin (MS) and ankaflavin (AK) produced by Monascus purpureus NTU 568 were proven to show excellent hypolipidemic effects in our previous studies; however, the mechanism is still unclear. Methods This study used MS, AK, and monacolin K as test substances and performed tests on rats fed high-fat and high-cholesterol diet for 8 weeks. The lipid levels and the related protein levels of the rats were assessed to understand the effects of MS, AK, and monacolin K on lipid metabolism. Results MS and AK lowered low-density lipoprotein cholesterol (LDL-C) and preserved high-density lipoprotein cholesterol contents. MS and AK inhibited acetyl-coenzyme A acetyltransferase, microsomal triglyceride transfer protein, and apolipoprotein (apo) B-100 expression, thereby preventing LDL assembly. In addition, enhanced LDL-receptor expression increased the transport of LDL-C to the liver for metabolism. MS and AK also significantly increase apo A1 expression, which facilitates high-density lipoprotein cholesterol formation. Conclusion Monascus- fermented MS and AK can perform blood lipid regulation via the suppression of LDL-C assembly and stimulation of apo A1 expression in liver.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1684-1182
1995-9133
DOI:10.1016/j.jmii.2016.06.003